A novel combination immunotherapy shows promise in treating an aggressive type of B-cell lymphoma, according to new research presented by Dr. Jennifer Amengual and team at the ASH Annual Meeting
A rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
As a nationally and internationally renowned lymphoma physician-scientist, Barbara Pro, MD, has dedicated her career to better understanding the disease and uncovering possible treatments.
Study findings not only show that these mutations can contribute to diffuse large B cell lymphoma, but they identify an approach that should be useful for the analysis of other types of tumors.